Skip to main content
Clinical Trials/NCT06093971
NCT06093971
Completed
Not Applicable

Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot-assisted Laparoscopic Prostatectomy: A Randomized Controlled Study

Yonsei University1 site in 1 country112 target enrollmentNovember 17, 2023

Overview

Phase
Not Applicable
Intervention
remimazolam
Conditions
Prostate Tumor
Sponsor
Yonsei University
Enrollment
112
Locations
1
Primary Endpoint
Hypotension occurrence (unit: number of patients)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The investigators conduct a random assignment into either the remimazolam group or the propofol group. Depending on the group assignment, either remimazolam (0.2 mg/kg) or propofol (1.0 mg/kg) is administered. If necessary, additional doses of remimazolam (0.1 mg/kg) or propofol (0.5 mg/kg) are given. The standard anesthesia procedure of our institution is followed, and blood pressure data recorded during the surgery is analyzed (mean arterial pressure <65mmHg is defined as hypotension).

Registry
clinicaltrials.gov
Start Date
November 17, 2023
End Date
October 22, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who undergo robot-assisted laparoscopic prostatectomy and who have taken renin-angiotensin system blockers for more than 3 months.

Exclusion Criteria

  • emergency surgery
  • If the subject includes those who cannot read the consent form (e.g. illiterate, foreigners, etc.)
  • cognitive dysfunction
  • Atrial fibrillation, moderate to severe valvular disease, ejection fraction of 35% or less
  • Patients who did not take renin-angiotensin system blockers on the day of surgery

Arms & Interventions

Group remimazolam

During anesthesia induction, the remimazolam group (group R) receives remimazolam (0.2 mg/kg). If necessary, an additional dose of remimazolam (0.1 mg/kg) is administered.

Intervention: remimazolam

Group propofol

During anesthesia induction, the propofol group (group P) receives propofol (1.0 mg/kg). If necessary, an additional dose of propofol (0.5 mg/kg) is administered.

Intervention: Propofol

Outcomes

Primary Outcomes

Hypotension occurrence (unit: number of patients)

Time Frame: during the total anesthesia duration

"MAP\<65mmHg for 1 min

Vasopressor dose (unit: mcg for norepinephrine)

Time Frame: during the total anesthesia duration

total dose of norepinephrine administered

Amount of hypotension (unit: mmHg)

Time Frame: during the total anesthesia duration

time-weighted average MAP \<65mmHg =\> depth of hypotension (mmHg) below a MAP of 65 mmHg \* time (min) below a MAP of 65 mmHg)/ total duration of surgery (min)

Vasopressor dose (unit for vasopressin)

Time Frame: during the total anesthesia duration

total dose of vasopressin administered

Study Sites (1)

Loading locations...

Similar Trials